يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Goh, Jeffrey C"', وقت الاستعلام: 1.75s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.

    المؤلفون: Grünwald, Viktor, Powles, Thomas, Masatoshi Eto, Kopyltsov, Evgeny, Sun Young Rha, Porta, Camillo, Motzer, Robert, Hutson, Thomas E., José Méndez-Vidal, María, Sung-Hoo Hong, Winquist, Eric, Goh, Jeffrey C., Maroto, Pablo, Buchler, Tomas, Toshio Takagi, Burgents, Joseph E., Perini, Rodolfo, Cixin He, Okpara, Chinyere E., McKenzie, Jodi

    المصدر: Frontiers in Oncology; 2024, p1-10, 10p

    مصطلحات موضوعية: SUNITINIB, RENAL cell carcinoma, BONE metastasis, THERAPEUTICS, TREATMENT effectiveness, PROGRESSION-free survival

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management.

    المؤلفون: Pathmanathan, Shivanshan, Tariq, Arsalan, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Raveenthiran, Sheliyan, Wong, David, McBean, Rhiannon, Marsh, Phillip, Goodman, Steven, Dhiantravan, Nattakorn, Esler, Rachel, Dunglison, Nigel, Navaratnam, Anojan, Yaxley, John, Thomas, Paul, Pattison, David A., Goh, Jeffrey C., Gan, Chun Loo, Roberts, Matthew J.

    المصدر: European Journal of Nuclear Medicine & Molecular Imaging; Dec2023, Vol. 51 Issue 1, p295-303, 9p

    مصطلحات موضوعية: RENAL cell carcinoma, POSITRON emission tomography


    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms

    المؤلفون: Grünwald, Viktor, Powles, Thomas, Eto, Masatoshi, Kopyltsov, Evgeny, Rha, Sun Young, Porta, Camillo, Motzer, Robert, Hutson, Thomas E., Méndez-Vidal, María José, Hong, Sung-Hoo, Winquist, Eric, Goh, Jeffrey C., Maroto, Pablo, Buchler, Tomas, Takagi, Toshio, Burgents, Joseph E., Perini, Rodolfo, He, Cixin, Okpara, Chinyere E., McKenzie, Jodi, Choueiri, Toni K.

    المساهمون: Grünwald, Viktor, Powles, Thoma, Eto, Masatoshi, Kopyltsov, Evgeny, Rha, Sun Young, Porta, Camillo, Motzer, Robert, Hutson, Thomas E., Méndez-Vidal, María José, Hong, Sung-Hoo, Winquist, Eric, Goh, Jeffrey C., Maroto, Pablo, Buchler, Toma, Takagi, Toshio, Burgents, Joseph E., Perini, Rodolfo, He, Cixin, Okpara, Chinyere E., Mckenzie, Jodi, Choueiri, Toni K.

    مصطلحات موضوعية: bone metastase, lenvatinib, liver metastase, lung metastase, pembrolizumab, renal cell carcinoma, sarcomatoid histology, sunitinib

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37664025; info:eu-repo/semantics/altIdentifier/wos/WOS:001059317200001; volume:13; firstpage:1223282; journal:FRONTIERS IN ONCOLOGY; https://hdl.handle.net/11586/464767Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85169664916

    الإتاحة: https://doi.org/10.3389/fonc.2023.1223282Test
    https://hdl.handle.net/11586/464767Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.

    المؤلفون: Grünwald, Viktor, Powles, Thomas, Masatoshi Eto, Kopyltsov, Evgeny, Sun Young Rha, Porta, Camillo, Motzer, Robert, Hutson, Thomas E., Méndez-Vidal, María José, Sung-Hoo Hong, Winquist, Eric, Goh, Jeffrey C., Maroto, Pablo, Buchler, Tomas, Takagi, Toshio, Burgents, Joseph E., Perini, Rodolfo, Cixin He, Okpara, Chinyere E., McKenzie, Jodi

    المصدر: Frontiers in Oncology; 2024, p1-2, 2p

    مصطلحات موضوعية: RENAL cell carcinoma, SUNITINIB, MEDICAL sciences

    النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial.

    المؤلفون: Motzer, Robert J1 (AUTHOR) motzerr@mskcc.org, Russo, Paul2 (AUTHOR), Grünwald, Viktor3 (AUTHOR), Tomita, Yoshihiko4 (AUTHOR), Zurawski, Bogdan5 (AUTHOR), Parikh, Omi6 (AUTHOR), Buti, Sebastiano7 (AUTHOR), Barthélémy, Philippe8 (AUTHOR), Goh, Jeffrey C9 (AUTHOR), Ye, Dingwei10 (AUTHOR), Lingua, Alejo11 (AUTHOR), Lattouf, Jean-Baptiste12 (AUTHOR), Albigès, Laurence13 (AUTHOR), George, Saby14 (AUTHOR), Shuch, Brian15 (AUTHOR), Sosman, Jeffrey16 (AUTHOR), Staehler, Michael17 (AUTHOR), Vázquez Estévez, Sergio18 (AUTHOR), Simsek, Burcin19 (AUTHOR), Spiridigliozzi, Julia20 (AUTHOR)

    المصدر: Lancet. Mar2023, Vol. 401 Issue 10379, p821-832. 12p.

    مصطلحات موضوعية: *RENAL cell carcinoma, *CLINICAL trials, *NIVOLUMAB, *IPILIMUMAB, *NEPHRECTOMY


    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study.

    المؤلفون: Motzer, Robert1 (AUTHOR) motzerr@mskcc.org, Porta, Camillo2,3 (AUTHOR), Alekseev, Boris4 (AUTHOR), Rha, Sun Young5 (AUTHOR), Choueiri, Toni K6 (AUTHOR), Mendez-Vidal, Maria Jose7 (AUTHOR), Hong, Sung-Hoo8 (AUTHOR), Kapoor, Anil9 (AUTHOR), Goh, Jeffrey C10 (AUTHOR), Eto, Masatoshi11 (AUTHOR), Bennett, Lee12 (AUTHOR), Wang, Jinyi12 (AUTHOR), Pan, Jie Janice13 (AUTHOR), Saretsky, Todd L14 (AUTHOR), Perini, Rodolfo F14 (AUTHOR), He, Cixin Steven13 (AUTHOR), Mody, Kalgi13 (AUTHOR), Cella, David15 (AUTHOR)

    المصدر: Lancet Oncology. Jun2022, Vol. 23 Issue 6, p768-780. 13p.

    مصطلحات موضوعية: *RENAL cell carcinoma, *QUINOLINE, *RESEARCH, *UREA, *CLINICAL trials, *RESEARCH methodology, *ANTINEOPLASTIC agents, *MONOCLONAL antibodies, *EVALUATION research, *COMPARATIVE studies, *RANDOMIZED controlled trials, *QUALITY of life, *RESEARCH funding


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث